UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000010960 |
|---|---|
| Receipt number | R000012828 |
| Scientific Title | A multi-institutional retrospective analysis of uterine carcinosarcoma |
| Date of disclosure of the study information | 2013/06/15 |
| Last modified on | 2013/06/14 11:46:43 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
A multi-institutional retrospective analysis of uterine carcinosarcoma
Acronym
retrospective analysis of uterine carcinosarcoma
Scientific Title
A multi-institutional retrospective analysis of uterine carcinosarcoma
Scientific Title:Acronym
retrospective analysis of uterine carcinosarcoma
Region
| Japan |
Condition
Condition
Uterine Carcinosarcoma
Classification by specialty
| Hematology and clinical oncology | Obstetrics and Gynecology |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
The objective of the retrospective analysis is to clarify the actual treatments and outcome of uterine carcinosarcoma, and to analize the prognostic factors.
Basic objectives2
Others
Basic objectives -Others
To analize the actual surgical, radiation, and chemotherapy outcome, and to clarify the prognostic factors influencing the treatment outcome.
Trial characteristics_1
Others
Trial characteristics_2
Explanatory
Developmental phase
Not applicable
Assessment
Primary outcomes
actual treatment and outcome
Key secondary outcomes
patient characteristics and pathological factors
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Female
Key inclusion criteria
patients who are newly, pathologically diagnosed as FIGO stage I-IV uterine carcinosarcoma
Key exclusion criteria
carcinosarcoma of ovary
recurrent uterinecarcinosarcoma
Target sample size
400
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Kenichi Harano |
Organization
Nippin MedicalSchool Musashikosugi Hospital
Division name
Department of Medical Oncology
Zip code
Address
1-396, Kosugi-cho, Nakahara-ku, Kawasaki City, Kanagawa
TEL
044-733-5181
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Hitoshi Sawada |
Organization
Japanese Gynecologic ONcology Group
Division name
Uterine Cancer committee
Zip code
Address
6-22-4F, Kagurazaka, Shinjuku-ku, Tokyo
TEL
03-5206-1982
Homepage URL
http://www.jgog.gr.jp/clinical_testing/clinical_testing.html
sawada@jgog.gr.jp
Sponsor or person
Institute
Japanese Gynecologic Oncology Group
Institute
Department
Personal name
Funding Source
Organization
Japanese Gynecologic Oncology Group
Organization
Division
Category of Funding Organization
Non profit foundation
Nationality of Funding Organization
Japan
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
日本婦人科悪性腫瘍研究機構加盟施設
Other administrative information
Date of disclosure of the study information
| 2013 | Year | 06 | Month | 15 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Enrolling by invitation
Date of protocol fixation
| 2012 | Year | 11 | Month | 30 | Day |
Date of IRB
Anticipated trial start date
| 2013 | Year | 01 | Month | 01 | Day |
Last follow-up date
| 2013 | Year | 09 | Month | 30 | Day |
Date of closure to data entry
| 2013 | Year | 09 | Month | 30 | Day |
Date trial data considered complete
| 2013 | Year | 09 | Month | 30 | Day |
Date analysis concluded
| 2013 | Year | 10 | Month | 31 | Day |
Other
Other related information
Now in enrolling cases
Management information
Registered date
| 2013 | Year | 06 | Month | 14 | Day |
Last modified on
| 2013 | Year | 06 | Month | 14 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000012828
